Definitive Healthcare (DH) Research & Development (2020 - 2026)

Definitive Healthcare has reported Research & Development for 7 years, with the latest figure at $6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 30.13% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $32.0 million (down 10.4% YoY), and the FY2025 full-year result was $34.8 million, down 4.77% from the prior year.
• Research & Development for Q1 2026 stood at $6.5 million, down from $10.0 million in the prior quarter.
• The five-year high for Research & Development was $11.6 million in Q4 2023, with the low at $6.5 million in Q1 2026.
• Historically, Research & Development has averaged $9.1 million across 5 years, with a median of $9.3 million in 2025.
• Annual changes were most pronounced in 2022 — Research & Development jumped 103.55% — and 2024, when it tumbled 32.32%.
• Definitive Healthcare's Research & Development stood at $10.1 million in 2022, then advanced by 14.22% to $11.6 million in 2023, then slipped by 22.36% to $9.0 million in 2024, then climbed by 10.82% to $10.0 million in 2025, then tumbled by 34.71% to $6.5 million in 2026.
• The last three Research & Development figures came in at $6.5 million (Q1 2026), $10.0 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.